Nurix Therapeutics OverviewNurix Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NRIX.
Quarterly EBIT
-$92.50M
↓ 47.14% YoY
As of Feb 28, 2026
Annual EBIT (TTM)
-$305.46M
↓ 32.42% YoY
Trailing 12 months ending Feb 28, 2026
Nurix Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for NRIX.
As of Feb 28, 2026
Trailing 12 months ending Feb 28, 2026